National Institutes of Health Center for Translational Therapeutics
NCTT is now part of the NIH National Center for Advancing Translational Sciences (NCATS). Content on this site will move to NCATS.NIH.GOV

Collection of approved drugs a promise for new therapies

Earlier this year, researchers at the NIH Center for Translational Therapeutics (NCTT), began screening the first definitive collection of thousands of approved drugs for clinical use against rare and neglected diseases. They are hunting for additional uses of the drugs, hoping to find off-label therapies for some of the 6,000 rare diseases that afflict 25 million Americans. (more)

See All NCTT News Features

Our Outcomes and Resources

NCTT produces a number of outcomes and resources along the translational therapeutics pipeline that can be used by the scientific community.

Translational Therapeutics Pipeline

For more detailed information about NCTT and its activities in the translational therapeutics pipeline, view the full interactive version.

Looking For?